Incidence of cervical lesions in Danish women before and after implementation of a national HPV vaccination program.
作者： Birgitte Baldur-Felskov , Christian Dehlendorff , Jette Junge , Christian Munk , Susanne K. Kjaer
DOI: 10.1007/S10552-014-0392-4
关键词:
摘要: Purpose Approximately 70 % of cervical cancers and about 50 high-grade precursor lesions are caused by human papillomavirus (HPV) types 16 18. Denmark introduced the quadrivalent HPV vaccine into vaccination program for 12-year-old girls in 2009 supplemented a first catch-up 13–15-year-old 2008, second women up to age 27 years 2012; all with high coverage. The aim this study was evaluate effectiveness comparing incidence trends before after its introduction.
springer.com
sci-hub.se 参考文章(34)
Peter McCullagh, John Ashworth Nelder, Generalized Linear Models ,(1983)
J. Rask, E. Lynge, M. Franzmann, B. Hansen, A. Hjortebjerg, C. Rygaard, D. Schledermann, A. Wåhlin, M. Rebolj, Impact of technology on cytology outcome in cervical cancer screening of young and older women International Journal of Cancer. ,vol. 134, pp. 2168- 2179 ,(2014) , 10.1002/IJC.28532
Bethany A Weaver, Epidemiology and natural history of genital human papillomavirus infection. The Journal of the American Osteopathic Association. ,vol. 106, ,(2006)
John T. Schiller, Xavier Castellsagué, Suzanne M. Garland, A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines Vaccine. ,vol. 30, ,(2012) , 10.1016/J.VACCINE.2012.04.108
Sidsel S. Barken, Matejka Rebolj, Elsebeth Lynge, Jette Junge, Carsten Rygaard, Outcomes in cervical screening using various cytology technologies: what's age got to do with it? European Journal of Cancer Prevention. ,vol. 22, pp. 367- 373 ,(2013) , 10.1097/CEJ.0B013E328359CBE0
Jan M. M. Walboomers, Marcel V. Jacobs, M. Michele Manos, F. Xavier Bosch, J. Alain Kummer, Keerti V. Shah, Peter J. F. Snijders, Julian Peto, Chris J. L. M. Meijer, Nubia Mu�oz, Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. The Journal of Pathology. ,vol. 189, pp. 12- 19 ,(1999) , 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
Margaret Stanley, Pathology and epidemiology of HPV infection in females. Gynecologic Oncology. ,vol. 117, ,(2010) , 10.1016/J.YGYNO.2010.01.024
Suzanne M. Garland, Jennifer S. Smith, Human papillomavirus vaccines: current status and future prospects. Drugs. ,vol. 70, pp. 1079- 1098 ,(2010) , 10.2165/10898580-000000000-00000
Dorota M Gertig, Julia ML Brotherton, Alison C Budd, Kelly Drennan, Genevieve Chappell, A Marion Saville, Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study. BMC Medicine. ,vol. 11, pp. 227- 227 ,(2013) , 10.1186/1741-7015-11-227
Bente Braad Sander, Matejka Rebolj, Palle Valentiner-Branth, Elsebeth Lynge, Introduction of human papillomavirus vaccination in Nordic countries. Vaccine. ,vol. 30, pp. 1425- 1433 ,(2012) , 10.1016/J.VACCINE.2011.11.097